Acute Myeloid Leukemia | Tumor

Venclexta With a Hypomethylating Agent Shows Promise for Patients with Acute Myeloid Leukemia

May 6th 2021, 9:00pm

Article

Compared to a hypomethylating agent alone, combining the agent with Venclexta improved complete remission rates in patients with blast-phase myeloproliferative neoplasm.

Why the COVID-19 Vaccine is Important for Patients with Blood Cancers

April 27th 2021, 9:00pm

Video

Patients with blood cancers are at a much higher risk of complications if they contract COVID-19, says an expert from the Leukemia & Lymphoma Society (LLS).

Post-Traumatic Stress Disorder Prevalent in Patients with Acute Myeloid Leukemia

April 21st 2021, 6:00pm

Article

Patients with acute myeloid leukemia experience post-traumatic stress disorder symptoms including intrusion, avoidance and hypervigilance one month after diagnosis.

FDA Approves Expanded Label of Vyxeos to Include Pediatric Patients with Secondary AML

March 31st 2021, 12:30am

Article

The agency granted approval to the revised label of Vyxeos to now include treatment for newly diagnosed therapy-related acute myeloid leukemia or disease with myelodysplasia-related changes in pediatric patients aged 1 and older.

‘Attitude is Everything’ When Dealing with Cancer

February 11th 2021, 4:00pm

Podcast

This week on the “CURE Talks Cancer” podcast, we spoke with Nicole Schulz, who was diagnosed with acute myeloid leukemia at the age of 14, about how her life changed as a result of her treatment and why she now lives life to the fullest.

Onureg Prolongs Survival in Acute Myeloid Leukemia

February 2nd 2021, 10:00pm

Article

Onureg, an oral form of the chemotherapy azacitidine, in older patients with acute myeloid leukemia who were in remission after chemotherapy contributed to longer survival outcomes, compared to placebo.

FDA Lifts Partial Hold on Trial Assessing Novel Therapy for Post-Transplant Acute Myeloid Leukemia

January 10th 2021, 3:00pm

Article

The FDA has lifted a partial clinical hold on a phase 2 trial evaluating a novel therapy in patients with acute myeloid leukemia following an allogenic stem cell transplant.

CURE’s Clinical Trial Corner: December 2020

December 31st 2020, 2:00pm

Article

Here is a list of some recent trials that launched within the cancer space in December.

The Top 10 FDA Oncology Drug Approvals of 2020

December 29th 2020, 2:00pm

Article

Here are the top 10 FDA oncology drug approvals that you may have missed this year.

The Top 5 News and Updates in Acute Myeloid Leukemia That Patients May Have Missed in 2020

December 26th 2020, 3:00pm

Article

A roundup of some of the most read news and updates in acute myeloid leukemia in 2020 from CURE®.